![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Reprints |
Permissions |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
REVIEWS
Gazzetta Medica Italiana Archivio per le Scienze Mediche 2000 October;159(5):159-63
Copyright © 2000 EDIZIONI MINERVA MEDICA
language: Italian
Marshall’s syndrome. A new periodic fever
Cau C.
DEA - dell’Azienda ospedaliera S. Giovanni Addolorata - Roma
A syndrome of periodic fever has been identified recently by Marshall in 12 children observed at two major referral centers. The acronym used to describe the syndrome is PFAPA (for fever, aphthosis, stomatitis, pharyngitis and cervical adenitis). Attacks characterized by abrupt onset of fever, malaise, chills, aphtosis, stomatitis, pharyngitis, hedache and tender cervical adenopathy occur at 4- to 6 week intervals over periods of years. These episodes of illness resolve spontaneously in 4 to 5 day. Mild leukocytosis and elevation of the erythrocyte sedimentation rate during attacks are the only laboratory abnormalities. Affected children grow normally. In some children the syndrome resolves, whereas symptoms fn others persist for years and complications have not been described. A number of other syndromes characterized by recurrent fever have been reported and compared with PFAPA: familial Mediterranean fever, the hyper-IgD syndrome, Behçet disease, hereditary angioedema, cyclic neutropenia, familial Hibernian fever. Attacks may aborted by short courses of prednisone but do not respond to non steroidal anti-inflammatory agents. Acetaminophen and antibiotic drugs were reported to have modest therapeutic benefit Cimetidine was suggested as a prophylactic treatment for PFAPA in 1992. It appeared to be highly effective in preventing attacks in some patients. However, we cannot explain why, when cimetidine was discontinued, PFAPA syndrome did not recur. Perhaps a permanent change in these patients’ immune systems followed the 6 to 8 months of cimetidine therapy. Another possibility is spontaneous remission.